Clinical Trials
3 trialsNCT00906373 2018-06-04
A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver
Eli Lilly and Company
Phase 2 Completed
NCT01008566 2016-05-12
Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00639509 2014-05-23
IMC-A12 in Treating Patients With Advanced Liver Cancer
National Cancer Institute (NCI)
Phase 2 Completed